Monoclonal antibody therapy for prevention of severe disease in nosocomial COVID-19

• Main Authors: Adam Zimilover (Author), Thien-Ly Doan (Author), Sumeet Jain (Author), Prashant Malhotra (Author)
• Formato: Livro
• Publicado em: Cambridge University Press, 2022-07-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background: In November 2020, the FDA issued an emergency use authorization (EUA) for monoclonal antibodies (mAbs) to be used in outpatients with COVID-19 infections who are at a high risk of progressing to severe disease. However, becuase the EUA had limited indications for inpatients, data on thei...